{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:08:03Z","timestamp":1789834083891,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T00:00:00Z","timestamp":1151020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of the current study was to assess the antidepressant efficacy and safety of <jats:italic>Hypericum perforatum<\/jats:italic> (St. John's wort) extract WS<jats:sup>\u00ae<\/jats:sup> 5570 at doses of 600 mg\/day in a single dose and 1200 mg\/day in two doses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The participants in this double-blind, randomized, placebo-controlled, multi-center clinical trial were male and female adult out-patients with an episode of mild or moderate major depressive episode (single or recurrent episode, DSM-IV criteria). As specified by the relevant guideline, the study was preceded by a medication-free run-in phase. For the 6-week treatment, 332 patients were randomized: 123 to WS<jats:sup>\u00ae<\/jats:sup> 5570 600 mg\/day, 127 to WS<jats:sup>\u00ae<\/jats:sup> 5570 1200 mg\/day, and 82 to placebo. The primary outcome measure was the change in total score on the Hamilton Rating Scale for Depression (HAM-D, 17-item version) between baseline and endpoint. Additional measures included the number of responders, the number of patients in remission, and several other standard rating scales. Efficacy and safety were assessed after 2 and 6 weeks. The design included an interim analysis performed after randomization with the option of early termination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>After 6 weeks of treatment, mean \u00b1 standard deviation decreases in HAM-D total scores of 11.6 \u00b1 6.4, 10.8 \u00b1 7.3, and 6.0 \u00b1 8.1 points were observed for the WS<jats:sup>\u00ae<\/jats:sup> 5570 600 mg\/day, 1200 mg\/day and placebo groups, respectively (endpoint analysis). Secondary measures of treatment efficacy also showed that both WS<jats:sup>\u00ae<\/jats:sup> 5570 groups were statistically superior to placebo. Significantly more patients in the WS<jats:sup>\u00ae<\/jats:sup> 5570 treatment groups than in the placebo group showed treatment response and remission. WS<jats:sup>\u00ae<\/jats:sup> 5570 was consistently more effective than placebo in patients with either less severe or more severe baseline impairment. The number of patients who experienced remission was higher in the WS<jats:sup>\u00ae<\/jats:sup> 5570 1200 mg\/day group than the WS<jats:sup>\u00ae<\/jats:sup> 5570 600 mg\/day group. The incidence of adverse events was low in all groups. The adverse event profile was consistent with the known profile for <jats:italic>Hypericum<\/jats:italic> extract preparations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>\n              <jats:italic>Hypericum perforatum<\/jats:italic> extract WS<jats:sup>\u00ae<\/jats:sup> 5570 at doses of 600 mg\/day (once daily) and 1200 mg\/day (600 mg twice daily) were found to be safe and more effective than placebo, with comparable efficacy of the WS<jats:sup>\u00ae<\/jats:sup> 5570 groups for the treatment of mild to moderate major depression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1741-7015-4-14","type":"journal-article","created":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T18:33:21Z","timestamp":1151087601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Superior efficacy of St John's wort extract WS\u00ae5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]"],"prefix":"10.1186","volume":"4","author":[{"given":"Siegfried","family":"Kasper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion-George","family":"Anghelescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Dienel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinhard","family":"Kieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,6,23]]},"reference":[{"issue":"6","key":"77_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0944-7113(98)80039-1","volume":"5","author":"G Laakmann","year":"1998","unstructured":"Laakmann G, Dienel A, Kieser M: Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities. Phytomedicine. 1998, 5 (6): 435-442.","journal-title":"Phytomedicine"},{"issue":"Suppl","key":"77_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/s-2007-979346","volume":"31","author":"G Laakmann","year":"1998","unstructured":"Laakmann G, Sch\u00fcle C, Baghai T, Kieser M: St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 1998, 31 (Suppl): 54-59.","journal-title":"Pharmacopsychiatry"},{"key":"77_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-2001-14280","volume":"34","author":"R Kalb","year":"2001","unstructured":"Kalb R, Trautmann-Sponsel RD, Kieser M: Efficacy and tolerability of Hypericum extract WS5572 versus placebo in mildly to moderately depressed patients. Pharmacopsychiatry. 2001, 34: 96-103. 10.1055\/s-2001-14280.","journal-title":"Pharmacopsychiatry"},{"key":"77_CR4","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1176\/appi.ajp.159.8.1361","volume":"159","author":"Y Lecrubier","year":"2002","unstructured":"Lecrubier Y, Clerc G, Didi R, Kieser M: Efficacy of St. John's wort extract WS5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry. 2002, 159: 1361-1366. 10.1176\/appi.ajp.159.8.1361.","journal-title":"Am J Psychiatry"},{"key":"77_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2007-979524","volume":"30","author":"EU Vorbach","year":"1997","unstructured":"Vorbach EU, Arnoldt KH, H\u00fcbner WD: Efficacy and tolerability of St. John's Wort Extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry. 1997, 30: 81-85.","journal-title":"Pharmacopsychiatry"},{"key":"77_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<163::AID-HUP5>3.0.CO;2-I","volume":"13","author":"E Schrader","year":"1998","unstructured":"Schrader E, Meier B, Brattstr\u00f6m A: Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol. 1998, 13: 163-169. 10.1002\/(SICI)1099-1077(199804)13:3<163::AID-HUP5>3.0.CO;2-I.","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"77_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1185\/135525701750167492","volume":"7","author":"S Kasper","year":"2001","unstructured":"Kasper S, Trautmann-Sponsel RD: St John's wort extract: an effective and well-tolerated antidepressant. Primary Care Psychiatry. 2001, 7 (1): 39-42. 10.1185\/135525701750167492.","journal-title":"Primary Care Psychiatry"},{"key":"77_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.phymed.2004.02.004","volume":"12","author":"K Linde","year":"2005","unstructured":"Linde K, Kn\u00fcppel L: Large-scale observational studies of hypericum extracts in patients with depressive disorders-a systematic review. Phytomedicine. 2005, 12: 148-157. 10.1016\/j.phymed.2004.02.004.","journal-title":"Phytomedicine"},{"issue":"Suppl 1","key":"77_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/089198879400700105","volume":"7","author":"WD H\u00fcbner","year":"1994","unstructured":"H\u00fcbner WD, Lande S, Pozuweit H: Hypericum treatment of mild depressions with somatic symptoms. J Geriatr Psychiatry Neurol. 1994, 7 (Suppl 1): 12-14.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"Suppl 1","key":"77_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/089198879400700104","volume":"7","author":"H Sommer","year":"1994","unstructured":"Sommer H, Harrer G: Placebo-controlled double-blind study examining the effectiveness of an Hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol. 1994, 7 (Suppl 1): 9-11.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"77_CR11","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/jama.285.15.1978","volume":"285","author":"RC Shelton","year":"2001","unstructured":"Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U: Effectiveness of St John's Wort in Major Depression. JAMA. 2001, 285: 1978-1986. 10.1001\/jama.285.15.1978.","journal-title":"JAMA"},{"key":"77_CR12","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1001\/jama.287.14.1807","volume":"287","author":"Hypericum Depression Trial Study Group","year":"2002","unstructured":"Hypericum Depression Trial Study Group: Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder. JAMA. 2002, 287: 1807-1814. 10.1001\/jama.287.14.1807.","journal-title":"JAMA"},{"key":"77_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/01.jcp.0000178416.60426.29","volume":"25","author":"M Fava","year":"2005","unstructured":"Fava M, Alpert J, Nierenberger AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF: A Double-blind, Randomized Trial of St John's Wort, Fluoxetine, and Placebo in Major Depressive Disorder. J Clin Psychopharmacol. 2005, 25: 441-447. 10.1097\/01.jcp.0000178416.60426.29.","journal-title":"J Clin Psychopharmacol"},{"key":"77_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.186.2.99","volume":"186","author":"K Linde","year":"2005","unstructured":"Linde K, Berner M, Egger M, Mulrow C: St John's wort for depression: Meta-analysis of randomised controlled trials. Br J Psychiatry. 2005, 186: 99-107. 10.1192\/bjp.186.2.99.","journal-title":"Br J Psychiatry"},{"key":"77_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00213-002-1203-2","volume":"164","author":"S Kasper","year":"2002","unstructured":"Kasper S, Dienel A: Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology. 2002, 164: 301-308. 10.1007\/s00213-002-1203-2.","journal-title":"Psychopharmacology"},{"key":"77_CR16","first-page":"CD000448","volume":"2","author":"K Linde","year":"2005","unstructured":"Linde K, Mulrow CD, Berner M, Egger M: St John's wort for depression. Cochrane Database Syst Rev. 2005, 2: CD000448.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"77_CR17","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1055\/s-2007-979528","volume":"30","author":"WE M\u00fcller","year":"1997","unstructured":"M\u00fcller WE, Rolli M, Sch\u00e4fer C, Hafner U: Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry. 1997, 30 (Suppl 2): S102-S107.","journal-title":"Pharmacopsychiatry"},{"key":"77_CR18","first-page":"145","volume":"45","author":"S Perovic","year":"1995","unstructured":"Perovic S, M\u00fcller WE: Pharmacological profile of Hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung. 1995, 45: 145-148.","journal-title":"Arzneimittelforschung"},{"key":"77_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/bmj.38356.655266.82","volume":"330","author":"A Szegedi","year":"2005","unstructured":"Szegedi A, Kohnen R, Dienel A, Kieser M: Acute treatment of moderate to severe depression with hypericum extract WS5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. Br Med J. 2005, 330: 503-506.","journal-title":"Br Med J"},{"key":"77_CR20","unstructured":"German Federal Health Office (BGA) Monograph: Hyperici herba (St. John's Wort) Commission E monograph. Bundesanzeiger. 1984 Dec. 5"},{"key":"77_CR21","first-page":"119","volume":"119","author":"R Rychlik","year":"2001","unstructured":"Rychlik R, Siedentop H, von den Driesch V, Kasper S: St. John's wort extract WS5572 in minor to moderately severe depression. Effectiveness and tolerance of 600 and 1200 mg ingredient daily. Fortschr Med Orig. 2001, 119: 119-128.","journal-title":"Effectiveness and tolerance of 600 and 1200 mg ingredient daily. Fortschr Med Orig"},{"key":"77_CR22","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington, DC, 4","edition":"4"},{"key":"77_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.313.7052.253","volume":"313","author":"K Linde","year":"1996","unstructured":"Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D: St John's wort for depression-an overview and meta-analysis of randomized clinical trials. Br Med J. 1996, 313: 253-258.","journal-title":"Br Med J"},{"key":"77_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2307\/2533441","volume":"50","author":"P Bauer","year":"1994","unstructured":"Bauer P, Koehne K: Evaluation of experiments with adaptive interim analyses. Biometrics. 1994, 50: 1029-1041. 10.2307\/2533441.","journal-title":"Biometrics"},{"key":"77_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/biomet\/46.1-2.36","volume":"46","author":"DJ Bartholomew","year":"1959","unstructured":"Bartholomew DJ: A test of homogeneity for ordered alternatives. Biometrika. 1959, 46: 36-48. 10.2307\/2332806.","journal-title":"Biometrika"},{"key":"77_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/biomet\/46.3-4.328","volume":"46","author":"DJ Bartholomew","year":"1959","unstructured":"Bartholomew DJ: A test of homogeneity of means under restricted alternatives. Biometrika. 1959, 46: 328-335. 10.2307\/2333530.","journal-title":"Biometrika"},{"key":"77_CR27","first-page":"638","volume":"32","author":"A Phillips","year":"1998","unstructured":"Phillips A: A review of the performance of tests used to establish whether there is a drug effect in dose-response studies. Drug Inf J. 1998, 32: 638-692.","journal-title":"Drug Inf J"},{"key":"77_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1081\/SAC-120028434","volume":"33","author":"DW Zimmerman","year":"2004","unstructured":"Zimmerman DW: Conditional probabilities of rejecting H0 by pooled and separate-variances t tests given heterogeneity of sample variances. Communications in Statistics: Simulation and Computation. 2004, 33: 69-81. 10.1081\/SAC-120028434.","journal-title":"Communications in Statistics: Simulation and Computation"},{"key":"77_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/(SICI)1521-4036(199906)41:3<261::AID-BIMJ261>3.0.CO;2-U","volume":"41","author":"M Kieser","year":"1999","unstructured":"Kieser M, Bauer P, Lehmacher W: Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biom J. 1999, 41: 261-277. 10.1002\/(SICI)1521-4036(199906)41:3<261::AID-BIMJ261>3.0.CO;2-U.","journal-title":"Biom J"},{"key":"77_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1176\/appi.psy.44.4.271","volume":"44","author":"P Hammerness","year":"2003","unstructured":"Hammerness P, Basch E, Ulbricht C, Barette EP, Foppa I, Basch S, Bent S, Boon H, Ernst E: St. John's Wort: A Systematic Review of Adverse Effects and Drug Interactions for the Consultation Psychiatrist. Psychosomatics. 2003, 44: 271-282. 10.1176\/appi.psy.44.4.271.","journal-title":"Psychosomatics"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-4-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-4-14\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-4-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:48:35Z","timestamp":1630450115000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-4-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-4-14","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,23]]},"assertion":[{"value":"29 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"14"}}